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ABSTRACT: While there has been extensive research on the link between depression and cardiovascular disease, few
reviews have summarized the array of findings. In this literature review, we examined approximately 50 clinical papers
and research studies to determine if reducing depression could reduce the risk of having a cardiovascular incident and
if reducing the severity of cardiovascular disease could reduce depression. We identified two major mechanisms through
which depression affects the cardiovascular system. We present evidence that depression and cardiovascular disease
may have a reciprocal relationship. For instance, depression is as much of a risk factor for heart disease as smoking and
hypertension. Further, depression is 20% more common in patients after a major cardiac event like a myocardial
infarction. In addition, we examine how treating depression could reduce the risk of developing a cardiovascular
disease.
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INTRODUCTION
Mental illness not only influences the psychological
aspects of the body, but it can also negatively impact the
physical body as a system. For example, depression is a
debilitating condition and the leading cause of disability
worldwide (Mata D, 2015). This disorder affects an
individual’s mood with a persistent feeling of sadness,
agitation, social isolation, and suicidal thoughts. In
addition, it could have physical implications in terms
of sleep, energy and appetite disturbance (Health
Guide, 2019). Mental illnesses can affect the physical
fitness of individuals. For instance, individuals with
depression may experience reduced energy and lack of
motivation. Further, a study of 51 hospitalized depressive
patients showed a correlation between the length of the
depressive episode and poorer physical performance
(Voderholzer U., 2011). This study demonstrates how
mental health has an impact in the entire body, including
the cardiovascular system.
Major depression is set to become the leading cause
of disability worldwide by the year 2030 (Khalid
Faroog, Asghar and Kanwal, 2017). It is established
that depression is more prevalent in people who suffer
major cardiac events. Depression influences people’s
behaviors and results in abnormal functioning of the
cardiovascular system. Currently, cardiovascular disease
is the number one cause of death globally; more people
die annually from cardiovascular disease than from
any other cause (World Health Organization, 2017).
Studies have suggested a possible reciprocal relationship
between the two illnesses. The presence of cardiovascular
disease in patients with depression, and, conversely, the
development of depression after a cardiac disease are
common. For instance, patients with heart failure and
depression have an increased risk of being readmitted
by heart failure exacerbation and, by consequence, suffer
a significant increase in mortality risk (Pozuelo, 2018;
Jiang, 2007). A study conducted on 374 patients with
congestive heart failure showed that patients with major
depression had higher readmission and mortality rates
compared to patients with mild or no depression. Also,
these patients were twice more likely to be readmitted or
die within three months to one year after a hospitalization
than non-depressed patients ( Jiang, 2001). Depression
can cause autonomic dysregulation, hyperproduction of
cortisol, prothrombotic and proinflammatory states that
are commonly seen in the development of heart failure
(Silver, 2010). In addition, symptoms of depression are
three times more common in patients after an acute heart
https://stars.library.ucf.edu/urj/vol13/iss1/1

attack than in the general population (Gebska, 2016).
Despite the overwhelming evidence of this relationship,
these diseases are rarely treated together. Preventive
measures should be taken when one of the diseases is
present.
Treatment for depression has been shown to reduce
the risk of developing cardiovascular diseases. The
combination of pharmacological and psychological
treatments appears to be effective in reducing depressive
symptoms in patients with cardiac disease and has
been shown to have a positive effect during recovery
after a major cardiac event. We seek to examine
the possible relationship between depression and
cardiovascular disease. Our inquiry explores whether
mitigating depression could decrease the risk of having
a cardiovascular incident and if reducing the severity of
cardiovascular disease could reduce depression.
METHODS
To investigate the relationship between depression and
cardiovascular disease, a literature review was conducted.
PubMed, the UCF Library database, and Google Scholar
were searched for clinical papers and research studies
pertaining to depression and cardiovascular disease. Key
words such as depression, cardiovascular disease, heart
disease, hypertension, arrhythmias, and stress were put
into each database’s respective search engine. Articles
containing these selected keywords were collected,
analyzed for their relevance, and then selected for
inclusion. The searches were limited to studies reported
in English between 1987 and 2019.
FINDINGS
Depression and Cardiovascular disease: a bidirectional
relationship
Depression is about twice as likely in people with
heart disease compared to the general population and,
similarly, people with depression present a higher risk of
developing heart disease (Harvard Heart Letter, 2016).
These figures indicate that the relationship between
depression and cardiovascular disease is bidirectional.
There is about an 80% increased risk of developing a
heart condition with depression, even if the patient
doesn’t present a history of cardiovascular disease
(Chaddha, Robinson, Kline-Rogers, AlexandrisSouphis, & Rubenfire, 2016). In addition, depression
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after a heart attack is common, especially in patients with
drastic procedures such as a coronary bypass. Procedures
like this have extensive periods of recovery and can be
stressful. This stress has been shown to take a toll on
the patient’s mental health. After surgery, it is common
for patients to have trouble sleeping and present with
fatigue; these symptoms are commonly found in patients
with depression (Harvard Mental Health Letter, 2009).
How might depression promote cardiovascular disease?
The effect of depression on the body and physical health
The American Heart Association lists depression as
a risk factor after a heart attack and as an accelerator
for atherosclerosis. One of the main reasons depression
contributes to the increased risk for cardiovascular
disease is the negative effects it has on patients’ lifestyles.
Depressive symptoms include anxiety, fatigue, anhedonia
(loss of interest in previously enjoyable activities),
and hopelessness (Lazarus, Newton, Cohler, Lesser,
& Schweon, 1987). Due to some of these symptoms,
individuals with depression tend to be less physically
active than non-depressed individuals (Paluska &
Schwenk, 2012). A study conducted on 106 patients,
among whom 48 were depressed, showed that 1/5 of the
depressed patients were initially motivated to start regular
physical activity. Only 1/4 of these patients completed the
whole program. In comparison all nondepressed patients
completed the program. The researchers hypothesized
that a possible reason for this result was that depression
reduces adherence to exercise regimes. Further, all
patients who continued with physical activity reported
their mood was better, even the depressed patients (Suija,
et al., 2009).
Furthermore, a study conducted on 3,486 individuals
concluded that depressed individuals are more likely
to crave sugar and carbohydrates (Akbaraly, Brunner,
Ferrie, & Marmot, 2018). These types of foods could
provide a short term benefits, such as comfort, but in
the long term, a high level of sugar and carbohydrates
in the diet increases the risk for chronic conditions
including diabetes, cancer, cardiovascular disease, and
more (Akbaraly, Brunner, Ferrie, & Marmot, 2018).
Another study showed that men are more susceptible
to the effects of sugars on mental health. The study
concluded that men who ate 67 grams or more of sugar
daily were 23% more likely to develop depression after
five years. The researchers did not find any association
between the amount of sugar ingested and incidents of
Published by STARS, 2021

depression in women. Although, higher intakes of sugar
were correlated to recurrent depression in both sexes
(Knuppel, Shipley, Llewellyn, & Brunner, 2017).
Depressed individuals may consume alcohol or engage
in substance abuse to improve their mood or escape
feeling of sadness, despair or guilt. This method of selfmedicating can make depressive episodes more severe
by increasing their frequency and intensity (American
Addiction Center, 2020). Statistically, depressed
individuals are more likely to report substance abuse than
individuals without depression. Alcohol dependence is
also two times greater in individuals with a history of
depression (Currie, 2005). The use of depressants like
alcohol can increase feelings of sadness and fatigue. A
study conducted on the comorbidity of major depression
with substance use showed that drug dependence is
four times more prevalent in depressed individuals
and increases the chances of having suicidal thoughts.
In addition, substance abuse increased the prevalence
of depression to 17% (Currie, 2005). Substance abuse
increases the severity of the mood disorders by increasing
the levels of stress experienced by the individual (Hasin
D, 2002). This stress affects the heart and increases the
risk of developing cardiovascular diseases.
In general, people with low physical activity, unbalanced
diets, and unhealthy substance dependence are more likely
to develop major depression and heart-related conditions
(Cabello, et al., 2017). A study conducted by Bonnet,
Irving and Nony showed that depressive symptoms
associated with unhealthy lifestyles are more common
in hypertensive patients. The presence of depressive
symptoms was significantly associated with unhealthy
diet practices such as high caloric intake (Bonnet, Irving,
Nony, Berthezene, & Moulin, 2005). This association
also included a decrease in physical activity and increased
smoking habits. The study showed that the prevalence of
depression was 6% higher in woman than in men (Imran
Shuja Khawaja, 2009). This gender gap was attributed
to unequal power and status, work overload and abuse
that women are more susceptible to experiencing (Mayo
Clinic, 2020).
Depression on the
cardiovascular disease

biological

mechanisms

of

The association between cardiovascular disease and
depression influences the normal physiological
processes of the body. Specifically, the activation of
the sympathetic nervous system and stress pathways
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are linked to unfavorable outcomes for a patient at
risk for cardiovascular disease. Also, the psychological
stress experienced by people with depression can
cause deregulation of the hypothalamic-pituitaryadrenal (HPA) axis (Chaddha, Robinson, KlineRogers, Alexandris-Souphis, & Rubenfire, 2016). The
activation of the sympathetic nervous system affects
the cardiovascular system directly through the “fight or
flight” response. During stress, oxygen demand increases.
The body reacts by releasing catecholamines, stress
hormones that constrict the blood vessels, reduce blood
flow, and increase heart rate. This reaction is known as
mental-stress-induced myocardial ischemia (MSIMI).
Furthermore, a study conducted on 98 patients
hospitalized for acute myocardial infarction showed a
positive association between depressive symptoms and
ischemia. The study evaluated both somatic and cognitive
depressive symptoms. Further, patients with coronary
artery disease showed an increased inflammatory
response to mental stress. This inflammation showed
a correlation with abnormal coronary microvascular
function, suggesting a possible mechanism of mental
stress-induced ischemia ( Jingkai Wei, 2014).
In depressed and anxious individuals, this response
may become constant. The high dose of catecholamines
may cause necrotic lesions in the myocardium. These
lesions are usually accompanied with inflammation and
fibrous scarring. Further, they may potentially destroy
the elastic lamellas and atrophy the wall of large vessels
(Haft, 1974).This damage might lead to conditions like
atherosclerosis. The basic mechanism for this condition
involves the lipid accumulation and inflammatory
activation in the vascular wall (Zmyslowski & Szterk,
2017). The damage to the laminar flow in shear stress
on the arterial wall triggers the accumulation of lipids
and fibrous elements in the arteries. This process,
known as atherosclerosis, is the primary cause of heart
disease and stroke (Lusis, 2000). These complications
can make the heart more susceptible to signals such as
changes in heartrate. This deregulation may contribute
to the development of serious heart conditions such
as hypertension, arrhythmias, platelet activation, and
coronary heart disease (Dhar & Barton, 2016).
Stress is related to the cardiovascular system and is part of
the proper functioning of the nervous system. Concerns
may arise when stress is constant, as this condition
affects behaviors and factors that increase the risk for
heart disease. Mental stress is one of the many cognitive
symptoms that people with depression suffer from. The
https://stars.library.ucf.edu/urj/vol13/iss1/1

induced activation of the HPA axis by depression and
the stress associated with it increases the release of stress
hormones like cortisol (Chaddha, Robinson, KlineRogers, Alexandris-Souphis, & Rubenfire, 2016). In
small quantities, cortisol prepares the body for physical
and emotional stress. In depressed patients, however,
cortisol production becomes problematic due to the
prolonged stress. Elevated levels of cortisol increase
blood sugar, low high-density lipoprotein, and blood
pressure. Further, high cortisol levels reduce the ability
of the body to fight infections, and increase fat storage in
the body (Dienes, Hazel, & Hammen, 2019).
Hypertension is a common condition that can have
long-term effects on the body. Uncontrolled high blood
pressure increases the risk of serious health problems.
Hypertension is often triggered and maintained by
mental stress. Stress increases the release and reduces the
uptake of norepinephrine (Delgado & Moreno, 2000).
Norepinephrine is a hormone and a neurotransmitter
that plays a role in circadian rhythms, attention, emotions
and memory. Increased levels of norepinephrine are
linked with panic attacks, elevated blood pressure, and
hyperactivity, while low levels cause fatigue, lack of
concentration and sometimes depression (Delgado
& Moreno, 2000). Elevated levels of norepinephrine
have been found in the plasma and the cerebrospinal
fluid of depressed patients (Dhar & Barton, March
2016). Further, a study conducted on 45 individuals
with chronic heart failure showed increased mortality
in patients suffering from major depression or with
norepinephrine plasma levels 40% greater than those of
the control group (Gold, 2005). Psychological distress
due to severe anxiety, constant stress, and recurring
depression can result in the release of epinephrine,
which also contributes to the increase of blood pressure
and constricts the arteries. During stress, the body
releases epinephrine, which triggers the “fight or flight”
response (Hormone Health, 2015). Repeated release of
epinephrine may lead to plaque disruption, myocardial
infarction, and, in more chronic cases, may cause an
aortic rupture (Gebska, 2016). Prolonged mental stress
has been shown to increase platelet activation and
endothelial dysfunction; both conditions are considered
early signs of cardiovascular deterioration (Grippo &
Johnson, 2009). Depression is also linked to low-grade
inflammation and is implicated with increased platelet
activity. This condition can increase the probability of the
thrombus formation and the rupture of cholesterol-filled
plaque (Chaddha, Robinson, Kline-Rogers, AlexandrisSouphis, & Rubenfire, 2016). The constant production
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of stress hormones due to depression activates
platelets, making them more likely to form clots in the
bloodstream. In fact, depression is associated with raised
platelet serotonin levels, promoting clotting (American
Psychiatric Association, 1994).
Cytokines are known for causing changes to the central
nervous system. Studies have examined the increase of
pro-inflammatory cytokines in elderly depressed patients
and in women experiencing post-partum depression. In
a study conducted by Faroog et al., cytokine levels were
directly proportional to the severity of the depression
(Khalid Faroog, Asghar and Kanwal, 2017). The cytokine
Interleukin-6 (IL-6) has been linked to stress-related
disorders such as depression and anxiety. The elevated
level of IL-6 in the blood of patients with depression is
caused by chronic stress. Evidence suggests that increases
of IL-6 also increase stress sensitivity (Hodes, Menard,
& Russo, 2016). In addition, there is evidence that
inflammation due to IL-6 plays a role in the development
of coronary heart disease and atherosclerosis. Elevated
levels of cytokines are associated with an increase in
blood viscosity and an increase in platelet number activity.
Further, IL-6 stimulates activation of the HPA axis; this
activation is associated with vascular damage, higher risk
of obesity, hypertension, and insulin resistance (Yudkin,
Kumari, Humphries, & Mohamed-Ali, 2000).
Depression after a Heart Attack
The American Heart Association recommends patients
who have suffered a heart attack be screened for
depressive symptoms. Major depression is 20% more
common in patients after a heart attack; during recovery,
20% of the patients might suffer from mild depression
(Woolston, 2019). The combination of major life

stressors contributes to the development of depression.
The emotional distress accompanied by the recovery
from a heart attack increases the risk of another heart
attack or any related cardiovascular disease (Williams,
2011). Once depression is present in the patients who
suffered a major cardiac event, it is expected for them
to still present depressive symptoms 4 months postdischarge (Dhar & Barton, March 2016).
Treating the Disorder
Depression impacts patients’ health, family members
and quality of life. Treating depression alleviates the
depressive symptoms affecting the body and the lifestyle
of the individual. Additionally, treatment decreases the
constant stress and anxiety that triggers the release of
stress hormones and disrupts the balance of the HPA
axis. Treatment has demonstrated improvements in
long-term cardiovascular health and increase quality of
life. Further, medications, therapy and non-medication
interventions such as exercise and meditation have
been shown to reverse the cardiovascular changes due
to the mental distress (Levine, 2017; Ornish, 1997).
Patients suffering from depression who haven’t been
diagnosed with cardiovascular diseases can benefit from
regular exercise, better nutrition, and stress management
techniques. These factors decrease the risk of developing
recurrent depression and cardiovascular disease.
Various antidepressants are available to manage
symptoms of depression, but it is important to
evaluate the cardiovascular risk before prescribing
( Jiang & Davidson, 2005). The production of effective
medications for the treatment of depression and
patients with cardiovascular disease has increased
over time. Some examples of antidepressants include

Table 1. List of possible mechanisms that may lead to cardiovascular disease
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CVD= Cardiovascular Disease; HF=Heart Failure
Table 2. Summary of preventive studies of depression and cardiac conditions.
SSRIs (selective serotonin reuptake inhibitors), SNRIs
(serotonin-norepinephrine reuptake inhibitors), TCAs
(tricyclic antidepressants), MAOIs (monoamine oxidase
inhibitors) and antidepressants that work by other
mechanisms (Rosenberg, 2014). Extensive research
has been conducted to develop safe antidepressants for
cardiac patients. One of the largest randomized trials
in this subject is the Sertraline Antidepressant Heart
Attack Randomized Trial (SADHART). The study
was conducted with 369 participants who developed
depression after a hospitalization for acute coronary
syndrome. Randomly selected individuals took either
https://stars.library.ucf.edu/urj/vol13/iss1/1

an SSRI or a placebo. The results suggested that SSRIs
protected the individuals by reducing platelet activation
(Glassman, O'Connor, & Califf, 2002).
However, no data was found on how psychotherapy by
itself affects the outcome of cardiovascular disease in
patients with depression. According to our findings, no
study has examined whether psychological treatment
for depression reduces the risk for cardiovascular
disease (Steward, Perkins, & Callahan, 2014). However,
other studies have concluded that the combination of
medication and psychological treatment may reduce
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anxiety, stress and depression; therefore, psychological
treatment may decrease the risk of developing
cardiovascular disease (Dhar & Barton, 2016).
Research on Prevention
The connection between cardiovascular disease and
depression is evident. The relationship between these
two conditions increases the intensity and severity of
each. Evidence from observational studies demonstrates
that treating depression may prevent cardiac events.
A study conducted by Steward, Perkins, and Callahan
focused on the treatment of depression for high-risk
cardiac patients. Their results showed that treatment
reduced the risk of having a chronic cardiac condition to
50%, see Table 2 (Steward, Perkins, & Callahan, 2014).
Their finding indicated that treating depression reduces
the risk of developing cardiovascular events, such as
strokes and coronary heart disease. In addition, the data
suggests that complementing recovery with a preventive
depression mindset improves the cardiovascular
prognosis (Rosenberg, 2014).

shown to increase heart and mental health. During
treatment for either condition, studies suggest that
having a preventive mentality can improve patients’
psychological and physiological condition. To optimize
patients’ outcomes and prevent the comorbidity of
depression and cardiovascular disease, it is important for
patients to discuss mental health with their doctors. The
stigma around this conversation is what causes mental
illness to go undiagnosed. Further, future studies could
examine if the psychological and clinical treatments for
depression can decrease the probability of developing
cardiovascular diseases. Understanding the comorbidity
of these conditions could also encourage future clinical
preventive measures that decrease the intensity of
depressive symptoms and, by consequence, decrease the
risk of developing cardiovascular disease.

CONCLUSION
The bidirectional correlation between cardiovascular
disease and depression should be a present concern
when treating patients with one of these conditions.
Preventive measures for these disorders have shown
positive outcomes. Those suffering from depression have
a higher risk of developing cardiovascular diseases due to
the constant production of stress hormones. The constant
stress and anxiety patients may experience during
depression could affect the physiological mechanism
of the HPA axis. These changes in the homeostatic
and neuroendocrine function increase the risk of
developing cardiovascular diseases. At the same time,
the manifestation of depressive symptoms could affect
the individual’s lifestyle. If this condition is accompanied
by an unbalanced diet, low physical activity, and
unhealthy substance dependence, the risk of developing
cardiovascular diseases increases. Further, cardiovascular
conditions such as heart attacks and heart failure are
usually accompanied by emotional distress. These events
may increase the probability of developing depressive
symptoms, which complicates the recovery process.
The combination of psychotherapy and antidepressants
has shown positive outcomes by increasing quality
of life. Non-medical interventions such as exercise,
meditation, and breathing exercises have also been
Published by STARS, 2021
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